Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Market price (% of par)
-
95.54%
-
Total 13F principal
-
$541,120,833
-
Principal change
-
-$12,342,167
-
Total reported market value
-
$516,289,488
-
Number of holders
-
44
-
Value change
-
-$13,969,065
-
Number of buys
-
31
-
Number of sells
-
14
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q1 2021
As of 31 Mar 2021 IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 had 44 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $541,120,833 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included DeepCurrents Investment Group LLC, ADVENT CAPITAL MANAGEMENT /DE/, WOLVERINE ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, STEELHEAD PARTNERS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CAMDEN ASSET MANAGEMENT L P /CA, Thrivent Financial for Lutherans, Verition Fund Management LLC, and PFM Health Sciences, LP.
This table shows 44 bond principal holders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.